Decision Support · Side-by-side
Compare pricing, strengths, and use cases so it is easier to pick the right fit.
Change tools
Neither Aqemia nor Entos is for everyday users—they are enterprise-grade drug discovery platforms for pharmaceutical researchers. Aqemia wins for teams needing data-free, physics-driven molecule generation, while Entos leads in accuracy for molecular property prediction. The single biggest difference: Aqemia explores massive chemical spaces without training data, whereas Entos combines physics and machine learning for higher precision on known targets.
Aqemia
Entos
Scores at a glance
Choose Aqemia if
Choose Entos if
Key differences
Facts side by side
| Aqemia | Entos | |
|---|---|---|
| Free plan | ||
| Mobile app | ||
| API access |
Common questions
No. Neither tool has a mobile app or a web interface for phones. They are designed for high-performance computing clusters and require a desktop or server environment.
Probably not. Both have high entry costs and require computational chemistry expertise. Entos might be slightly more accessible because it offers expert support, but neither is budget-friendly for a startup.
Yes. Both tools require a strong background in computational chemistry or drug discovery. They are not designed for non-scientists or general AI users.
Neither publishes pricing. Based on their enterprise focus and pharma partnerships, expect costs in the tens to hundreds of thousands of dollars per project.
Entos claims highest-in-class accuracy for molecular property prediction, while Aqemia focuses on exploring new chemical space. For precision on known targets, Entos wins.
Aqemia and Entos are powerful but inaccessible for everyday users—both require a PhD in computational chemistry and a six-figure budget.
If you are a non-technical person looking for an AI tool to use in your daily life, neither Aqemia nor Entos is right for you—they are specialized enterprise platforms for drug discovery. Stick with consumer-friendly AI tools like ChatGPT or Midjourney for everyday tasks.